Immediate Impact

2 from Science/Nature 56 standout
Sub-graph 1 of 24

Citing Papers

Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
2021 Standout
Radiolabelling of nanomaterials for medical imaging and therapy
2021 Standout
3 intermediate papers

Works of Thomas E. Witzig being referenced

Phase I/II 90 Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma
2000

Author Peers

Author Last Decade Papers Cites
Thomas E. Witzig 93 7 81 155 98 4 311
Dagmar Dohr 92 59 29 124 106 9 321
Ellen Kornmehl 40 21 26 218 145 6 366
Wilma G.J.M. Smit 37 36 21 60 35 7 275
A. Timothy 10 102 16 108 140 7 348
A McClure 37 8 57 136 126 4 350
Casely Ago 13 25 61 41 29 6 320
M. Bamberg 35 31 45 59 14 10 337
H Goldenberg 8 20 59 318 137 7 367
Jean Jacques Sotto 109 69 102 40 49 6 322
M. Slusarenko 57 23 103 111 36 6 366

All Works

Loading papers...

Rankless by CCL
2026